Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003006 · ClinicalTrials.gov registry record
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 501
- Enrollment target
NCT00003006: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00003006 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 501 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003006 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 501 participants
- Enrollment target
Study Summary
RATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer. PURPOSE: Clinical trial to detect the presence of metastatic cancer in patients with stage I non-small cell lung cancer that has not been previously treated.
Interventions
- OTHER immunohistochemistry staining method
- GENETIC reverse transcriptase-polymerase chain reaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 1997-05 |
| Est. Completion | 2010-06 |
What the finished NCT00003006 record still lists
NCT00003006 is an observational study that tracks outcomes without assigning an intervention. The registered 501 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which immunohistochemistry staining method is the first listed.
NCT00003006 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003006 about?
NCT00003006 is a clinical study titled "Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer". RATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer. PURPOSE: Clinical trial to detect the presence of metastatic cancer in patients with stage I non-small cell lung cancer that has not been previously tr...
What is the current status of trial NCT00003006?
This trial is currently completed. The enrollment target is 501 participants. The study started on 1997-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00003006?
The interventions under investigation include: immunohistochemistry staining method (OTHER), reverse transcriptase-polymerase chain reaction (GENETIC).
Who is sponsoring clinical trial NCT00003006?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- NCT06934525 · 501 participants · NA
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia